INDU.A

332.4

+1.03%↑

INDU.C

332.5

+0.91%↑

AZA

307.8

-3.63%↓

ORES

119.42

+1.84%↑

INDU.A

332.4

+1.03%↑

INDU.C

332.5

+0.91%↑

AZA

307.8

-3.63%↓

ORES

119.42

+1.84%↑

INDU.A

332.4

+1.03%↑

INDU.C

332.5

+0.91%↑

AZA

307.8

-3.63%↓

ORES

119.42

+1.84%↑

INDU.A

332.4

+1.03%↑

INDU.C

332.5

+0.91%↑

AZA

307.8

-3.63%↓

ORES

119.42

+1.84%↑

INDU.A

332.4

+1.03%↑

INDU.C

332.5

+0.91%↑

AZA

307.8

-3.63%↓

ORES

119.42

+1.84%↑

Search

Biotage AB

Avatud

140.7 -0.57

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

140.1

Max

141.6

Põhinäitajad

By Trading Economics

Sissetulek

97M

158M

Müük

92M

582M

P/E

Sektori keskmine

25.507

20.525

Aktsiakasum

1.416

Dividenditootlus

1.82

Kasumimarginaal

27.148

Töötajad

680

EBITDA

111M

222M

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.82%

4.36%

Järgmine tulemuste avaldamine

16. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-3.9B

7.2B

Eelmine avamishind

141.27

Eelmine sulgemishind

140.7

Biotage AB Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. apr 2025, 06:50 UTC

Omandamised, ülevõtmised, äriostud

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22. apr 2025, 06:04 UTC

Omandamised, ülevõtmised, äriostud

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22. apr 2025, 06:03 UTC

Omandamised, ülevõtmised, äriostud

KKR: Biotage Board Recommends Shareholders Accept Offer

22. apr 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

KKR: Offer Values Biotage at SEK11.61B

22. apr 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

KKR Makes SEK145 a Share Bid For Biotage

Võrdlus sarnastega

Hinnamuutus

Biotage AB Prognoos

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.